The global home healthcare market size was valued at USD 281.8 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2020 to 2027. Population aging around the world and increased patient preference for value-based healthcare are anticipated to fuel market growth. According to the World Health Organization (WHO), there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion by 2050. The aging population demands more patient-centric healthcare services, which in return increases the demand for healthcare workers and agencies and is anticipated to drive market growth.
The Bureau of Labor Statistics states that a growing workforce pertaining to healthcare service translates to the increasing demand for home health and personal healthcare aides and is expected to outpace the healthcare sector’s growth, with more than 4 million jobs only in the home healthcare sector.
Value-based healthcare is another major factor contributing to the market. In most of the developed and developing nations, the central government is offering either partial or complete coverage for the in-home services. In the U.S., Medicare reimbursements are highly favorable in providing value-based healthcare for improved patient outcomes at a low cost. Thus, in-home care has become a modality of choice for treatment.
In the U.S., Medicare is the largest single payer of home healthcare services. Medicare spending accounts for more than 40% of home health expenditures. Medicaid payments are divided into three main categories: the traditional home health benefit (mandatory), the personal healthcare option, and home and community-based waivers as an optional program. Collectively, these three home healthcare service categories hold a small share of total Medicaid payments.
In Europe, the central government offers some reimbursement benefits for this service. People are free to choose the providers and even the type of healthcare. But the central government does not completely cover the services being provided to the patients attributed to the division of home care into two parts i.e. healthcare and social care. Each part of service is covered by different financial sources and hence different rules govern eligibility, allocation, and administration.
By component, the home healthcare market has been segmented into equipment and services wherein the services segment dominated the market with a share of 80% in 2019. With the dramatic increase in the aging population worldwide, the demand for home healthcare agencies is increasing for better patient outcomes. In addition, the increasing prevalence of chronic diseases among the elderly is another major factor contributing to market growth.
The therapeutic devices dominated the equipment segment in 2019. The increasing number of patients suffering from chronic or acute respiratory illnesses or with urinary incontinence or end-stage renal disease (ESRD) demand advanced devices for treatment. In addition, reduced service charges for in-home healthcare when compared to hospital or nursing homes is another key factor boosting the therapeutic equipment market. According to the University of California, SF, around 750,000 patients per year in the U.S., and 2 million patients globally are affected by the end-stage renal disease (ESRD).
The diagnostics equipment segment is anticipated to witness lucrative growth during the forecast period attributed to the increasing prevalence of diabetes and cardiovascular diseases which needs continuous monitoring. In addition, increasing patient awareness levels towards screening process and technological advancements, integration of microfluidics, sensors, Internet-of-Things (IoT), smartphones and wearables bring point-of-care testing to the patients and represent a strong opportunity for providing sensitive, low-cost, rapid, and connected diagnostics.
North America dominated the home healthcare market with a share of around 42% in 2019. In North America, the U.S. held the largest market share in 2019 attributed to shifting trends towards in-home healthcare from nursing homes, technological advancement, and the presence of advanced medical infrastructure. In addition, high patient awareness levels coupled with increasing healthcare expenditure and the implementation of the streamlined regulatory framework are also driving the market in the region. Supportive initiatives by the Centers for Medicare and Medicaid Services are anticipated to propel market growth further.
Germany held the largest market share in Europe in 2019 followed by France. This is mainly due to increasing expenditure towards in-home healthcare in the country and growing demand for the skilled nursing workforce for in-house care.
The Asia Pacific is anticipated to witness the highest growth rate during the forecast period. The growing economy, high prevalence of chronic diseases, aging population, and skilled labor availability at economic costs, are the major factors enhancing the growth of this region. Japan held the largest market share attributed to the growth of the aging population and medical care associated with it. It is anticipated that by the year 2050 around 40% of the population in Japan will grow over 65 years of age. It is prominent in Tokyo where the percentage of 65 years old population is 25% in the year 2020 and is expected to be 30% of the total population by the year 2035.
The contributors to this market are divided into two categories i.e. manufacturers and service providers. Mergers and acquisition and the introduction of new services are key strategies followed by the market leaders. For instance, in February 2019, a Georgia based home healthcare company named Aveanna Healthcare underwent a definitive agreement to acquire the home healthcare division of Maxim Healthcare Services, a Maryland based home healthcare, and healthcare staffing service provider.
In October 2019, a leading software provider in the market for home healthcare named ClearCare, Inc., underwent an agreement to be acquired by WellSky Corporation, a health, and community care technology company. In July 2019, Net Health, an outpatient software provider, acquired Optima Healthcare Solutions, to enter into the home health and hospice segments of the post-acute healthcare service market. Optima’s post-acute care solution is mainly used by contract therapy companies, skilled nursing facilities (SNFs), continuing care retirement communities, and assisted living communities. In April 2017, McKesson Corporation acquired CoverMyMeds LLC, a company developing Electronic Prior Authorization (ePA) solutions. The company has automated the prior authorization process for more than 500 EHR systems, 700,000 providers, 49 thousand pharmacies, most health plans, and Pharmacy Benefit Managers (PBMs). Some of the prominent players in the home healthcare market include:
McKesson Medical-Surgical Inc.
Fresenius Medical Care
Medline Industries, Inc.
Baxter International Inc.
B. Braun Melsungen AG
F. Hoffmann-La Roche AG
Becton, Dickinson And Company
ConvaTec Group PLC
Molnlycke Health Care
Service Providers: -
Brookdale Senior Living, Inc.
Home Health Services Ltd.
Sunrise Carlisle, LP
Care UK Limited
Senior Care Centers of America
Genesis Healthcare Corp.
Sompo Holdings, Inc.
Kindred Healthcare, Inc.
Home Instead Senior Care, Inc.
Market size value in 2020
USD 303.6 billion in 2020
Revenue forecast in 2027
USD 515.6 billion
CAGR of 7.9% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company share, competitive landscape, growth factors & trends
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; UK; Germany; Sweden; France; Italy; Russia; Netherlands; Spain; Japan; China; India; Australia; Singapore; Thailand; Philippines; Korea; Malaysia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Oman; Egypt; UAE
Key companies profiled
McKesson Medical-Surgical Inc.; Fresenius Medical Care; Medline Industries, Inc.; Medtronic PLC; 3M Healthcare; Baxter International Inc.; B. Braun Melsungen AG; Arkray, Inc.; F. Hoffmann-La Roche AG; Becton, Dickinson And Company; Acelity L.P.; Hollister Inc.; ConvaTec Group PLC; Molnlycke Health Care; Brookdale Senior Living, Inc.; Home Health Services Ltd.; Sunrise Carlisle, LP; Extendicare, Inc.; Care UK Limited; Senior Care Centers of America; Genesis Healthcare Corp.; Sompo Holdings, Inc.; Kindred Healthcare, Inc.; and Home Instead Senior Care, Inc.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2016 to 2027. For this study, Grand View Research has segmented the global home healthcare market based on components and region:
Component Outlook (USD Million; 2016 - 2027)
Home respiratory equipment
Insulin delivery devices
Home IV pumps
Home dialysis equipment
Diabetic care unit
Multi para diagnostic monitors
Home pregnancy and fertility kits
Apnea and sleep monitors
Heart rate meters
Home medical furniture
Walking assist devices
Skilled home healthcare
Physical, occupational, and/or speech therapy
Hospice & palliative care
Other skilled home care services
Unskilled home healthcare
Regional Outlook (USD Million, 2016 - 2027)
Middle East & Africa
b. The global home healthcare market size was estimated at USD 281.8 billion in 2019 and is expected to reach USD 303.6 billion in 2020.
b. The global home healthcare market is expected to grow at a compound annual growth rate of 7.9% from 2020 to 2027 to reach USD 515.6 billion by 2027.
b. North America dominated the home healthcare market with a share of around 42% in 2019. This is attributable to shifting trends towards in-home healthcare from nursing homes, technological advancement, and the presence of advanced medical infrastructure.
b. Some key players operating in the home healthcare market include Brookdale Senior Living, Inc.; Home Health Services Ltd.; Sunrise Carlisle, LP; Extendicare, Inc.; Care UK Limited; Senior Care Centers of America; Genesis Healthcare Corp.; Sompo Holdings, Inc.; Kindred Healthcare, Inc.; and Home Instead Senior Care, Inc.
b. Key factors that are driving the market growth include population aging around the world and increased patient preference for value-based healthcare. The aging population demands more patient-centric healthcare services, which in return increases the demand for healthcare workers and agencies and is anticipated to drive market growth.
b. The services segment accounted for the major market share of 80% in 2019, in the home healthcare market.
b. As per the WHO, the number of people aged 65 years or more stood at 703 million globally in 2019, which has increased market scope for home healthcare services.
b. Asia Pacific is expected to become a major contributor to the home healthcare market revenue by 2027, owing to rising incidences of chronic diseases, a rapidly aging population, and the availability of low-cost skilled labor.
b. Some notable therapeutic devices include home respiratory equipment, home IV pumps, and insulin delivery devices; the diagnostic segment includes diabetic care unit, home pregnancy, and fertility kits, BP monitors, heart rate meters, and sleep monitors, among others.
b. The continued rise in the aging population around the globe translates to higher demand for patient-focused healthcare services, which is offered by the home healthcare industry.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.